Canine mammary mixed tumours: immunohistochemical expressions of EGFR and HER-2

Overexpression of EGFR and absence of C-KIT expression correlate with poor prognosis in salivary gland carcinomas

(2010) T Ettl et al.   HISTOPATHOLOGY

EGFR, pMAPK, pAkt and PTEN status by immunohistochemistry: correlation with clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumab

(2009) S. Gori et al.   ANNALS OF ONCOLOGY

Immunohistochemical expression of Epidermal Growth Factor Receptor (EGFR) in canine mammary tissues

(2009) A. Gama et al.   RESEARCH IN VETERINARY SCIENCE

Immunohistochemical Expression of p63 and ΔNp63 in Mixed Tumors of Canine Mammary Glands and Its Relation with p53 Expression

(2009) A. C. Bertagnolli et al.   VETERINARY PATHOLOGY

Invasive ductal carcinoma of the breast with the “triple-negative” phenotype: prognostic implications of EGFR immunoreactivity

(2008) Giuseppe Viale et al.   BREAST CANCER RESEARCH AND TREATMENT

Comparison of Her-2, EGFR and Cyclin D1 in Primary Breast Cancer and Paired Metastatic Lymph Nodes: An Immunohistochemical and Chromogenic In Situ Hybridization Study

(2008) Eun Yoon Cho et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Identification of molecular phenotypes in canine mammary carcinomas with clinical implications: application of the human classification

(2008) A. Gama et al.   VIRCHOWS ARCHIV

Increased survival in dogs with malignant mammary tumours overexpressing HER-2 protein and detection of a silent single nucleotide polymorphism in the canine HER-2 gene

(2007) Wei-Li Hsu et al.   VETERINARY JOURNAL